01
Research
Research establishes the scientific basis for any pharmaceutical programme: reviewing existing literature, understanding biological mechanisms and defining questions that can be tested.
Research & Development
Research & Development
Our focus is on identifying, evaluating and advancing opportunities where pharmaceutical science can contribute to meaningful innovation.
Pharmaceutical research and development is a long, staged and highly regulated process. Each stage exists to answer specific questions, and no stage can substitute for another.
The descriptions on this page explain how pharmaceutical development works in general. They do not indicate that Labse has commenced or completed any particular stage.
Development Pathway
The pharmaceutical development pathway
The standard pathway from discovery through to commercialisation, as it applies across the pharmaceutical industry. It describes development generally, not the status of any Labse programme.
- 01
Discovery
Identification and early evaluation of scientific opportunities.
- 02
Preclinical
Laboratory and non-clinical evaluation prior to human studies.
- 03
Clinical Development
Structured clinical evaluation conducted under applicable regulatory frameworks.
- 04
Regulatory
Preparation, submission and review of regulatory documentation.
- 05
Commercialisation
Supply, access and lifecycle activities following regulatory authorisation.
Stages
Stages of pharmaceutical development
02
Discovery
Discovery identifies and characterises candidate approaches. Work at this stage is exploratory, and most candidates do not progress beyond it.
03
Development
Development turns a candidate into something that can be evaluated consistently — formulation, analytical methods, stability and manufacturing considerations.
04
Preclinical Evaluation
Preclinical evaluation assesses pharmacology, toxicology and safety in non-clinical models, under recognised standards, before any human exposure is considered.
05
Clinical Development
Clinical development evaluates a candidate in humans through sequential phases, conducted under ethics approval and applicable regulatory oversight.
06
Regulatory Development
Regulatory development covers the preparation and submission of documentation to health authorities, and the ongoing obligations that follow.
Programme-specific information, including development status and any collaborations, will be published when it is appropriate for public disclosure.